Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial
Research output: Contribution to journal › Journal article › Research › peer-review
The aim of the study was to compare changes in bone mineral density (BMD) over 144 weeks in HIV-infected patients initiating nucleoside reverse transcriptase inhibitor (NRTI)-sparing or protease inhibitor-sparing highly active antiretroviral therapy (HAART).
Original language | English |
---|---|
Journal | HIV Medicine |
Volume | 12 |
Issue number | 3 |
Pages (from-to) | 157-65 |
Number of pages | 9 |
ISSN | 1464-2662 |
DOIs | |
Publication status | Published - 1 Mar 2011 |
ID: 40155059